https://www.openbell.ai/ 2026-09-24T16:37:44.772Z hourly 1.0 https://www.openbell.ai/support 2026-09-24T16:37:44.772Z monthly 0.7 https://www.openbell.ai/privacy 2026-09-24T16:37:44.772Z monthly 0.5 https://www.openbell.ai/terms 2026-09-24T16:37:44.772Z monthly 0.5 https://www.openbell.ai/feed.json 2026-09-24T16:37:44.772Z hourly 0.8 https://www.openbell.ai/news/NBIS:1790267635292 2026-09-24T16:33:55.292Z daily 0.9 https://cdn.brandfetch.io/NBIS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Nebius Group shares are trading higher after BNP Paribas upgraded the stock from Neutral to Outperform rating and raised its price target from $260 to $399. openbell Financial News https://www.openbell.ai/news/WELL:1790267434972 2026-09-24T16:30:34.972Z daily 0.9 https://cdn.brandfetch.io/WELL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Welltower shares are trading higher after JP Morgan upgraded the stock from Neutral to Overweight rating and announced a $260 price target. openbell Financial News https://www.openbell.ai/news/RCL:1790267275419 2026-09-24T16:27:55.419Z daily 0.9 https://cdn.brandfetch.io/RCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Royal Caribbean Cruises shares are trading higher after JP Morgan maintained its Overweight rating on the stock and raised its price target from $345 to $394. openbell Financial News https://www.openbell.ai/news/UTHR:1790267129167 2026-09-24T16:25:29.167Z daily 0.9 https://cdn.brandfetch.io/UTHR/w/400/h/400?c=1idopYfmtR7ZKg8QMud United Therapeutics shares are trading lower after Goldman Sachs initiated coverage on the stock with a Sell rating and announced a $321 price target. openbell Financial News https://www.openbell.ai/news/META:1790267105007 2026-09-24T16:25:05.007Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/In-this-photo-illustration--the-Meta-Mus.jpg?width=250&height=187 Here's How Meta's Muse Mania Is Spilling into Leveraged ETFs Meta Platforms, Inc. (NASDAQ: META) has seen its stock rise 3.38% to $769.22, nearing its 52-week high, following the launch of its Muse AI assistant on September 8, which has contributed to a 37% increase in the stock over the past month. The Muse launch has propelled Meta shares over 20% since its debut and has positively impacted leveraged ETFs, with the Leverage Shares 2X Long META Daily ETF (BATS: METG) gaining about 81% and the Direxion Daily META Bull 2X ETF (NASDAQ: METU) up approximately 82% in the same period. Analysts estimate that Muse could generate $10.8 billion in annual revenue by 2027 under aggressive adoption scenarios. https://www.openbell.ai/news/IONQ:1790267055971 2026-09-24T16:24:15.971Z daily 0.9 https://cdn.brandfetch.io/IONQ/w/400/h/400?c=1idopYfmtR7ZKg8QMud IonQ Signs Contract To Install Superion 256 Quantum Computer At Florida International University, Expected Late 2027; Terms Not Disclosed openbell Financial News https://www.openbell.ai/news/ACAD:1790266976223 2026-09-24T16:22:56.223Z daily 0.9 https://cdn.brandfetch.io/ACAD/w/400/h/400?c=1idopYfmtR7ZKg8QMud Acadia Pharma shares are trading lower after the company announced remlifanserin narrowly missed the primary endpoint in its Phase 2 RADIANT study for Alzheimer's disease psychosis. openbell Financial News https://www.openbell.ai/news/USO:1790266776994 2026-09-24T16:19:36.994Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud US And Iran Discuss Phased Deal To Reopen Strait Of Hormuz And End US Blockade, Sources Say US and Iran are reportedly in discussions regarding a phased deal aimed at reopening the Strait of Hormuz and ending the US blockade. This development could have significant implications for oil transportation and global markets, particularly affecting the USO stock, which is linked to oil prices. Further details on the negotiations and potential outcomes have not been disclosed. https://www.openbell.ai/news/USO:1790266537049 2026-09-24T16:15:37.049Z daily 0.9 https://cdn.brandfetch.io/USO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Oil is trading higher as U.S.-Iran tensions remain elevated after stalled bilateral talks, with Iranian President Pezeshkian saying "we will not bow to U.S. pressure." Several business groups warned President Trump against a planned diesel export ban, suggesting it would be counterproductive and raise fuel prices. openbell Financial News https://www.openbell.ai/news/GOOGL:1790266306321 2026-09-24T16:11:46.321Z daily 0.9 https://cdn.brandfetch.io/GOOGL/w/400/h/400?c=1idopYfmtR7ZKg8QMud BNP Paribas And Google Cloud Announce Five-Year Agentic AI And Cloud Partnership; Terms Not Disclosed BNP Paribas has announced a five-year partnership with Google Cloud focused on agentic AI and cloud innovation. The terms of the partnership have not been disclosed. This collaboration aims to enhance BNP Paribas's technological capabilities and improve customer services. https://www.openbell.ai/news/VLO:1790266014953 2026-09-24T16:06:54.953Z daily 0.9 https://cdn.brandfetch.io/VLO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Dozens Of U.S. Oil Refining And Business Groups Urge Trump To Reject Any Effort To Impose Ban On Diesel Exports Dozens of U.S. oil refining and business groups have sent a letter urging former President Trump to reject any efforts to impose a ban on diesel exports. The groups argue that such a ban would negatively impact the industry and the economy. This comes amid ongoing discussions about energy policies and their implications for the market. https://www.openbell.ai/news/LLY:1790265998532 2026-09-24T16:06:38.532Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Los-Angeles--California---July-7-2025-El.jpg?width=250&height=187 Lilly Wins FDA Nod For Weekly Insulin, Signs $3.25 Billion InnoCare Pact Eli Lilly and Co. received FDA approval for Onswik, a once-weekly insulin injection for type 2 diabetes, marking its fourth regulatory clearance globally. The approval was based on data from the QWINT Phase 3 clinical trials involving over 3,400 patients. Additionally, Lilly announced a strategic partnership with InnoCare Pharma, which could yield up to $3.25 billion in future milestone payments and royalties. Following these announcements, Lilly's stock rose by 3.42% to $1,190.32. https://www.openbell.ai/news/META:1790265688046 2026-09-24T16:01:28.046Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud Tigress Financial Maintains Strong Buy on Meta Platforms, Raises Price Target to $995 Tigress Financial analyst Ivan Feinseth has reiterated a Strong Buy rating on Meta Platforms (NASDAQ: META) and increased the price target from $945 to $995. This adjustment reflects positive sentiment towards the company's performance and growth potential. https://www.openbell.ai/news/GOOG:1790265582015 2026-09-24T15:59:42.015Z daily 0.9 https://cdn.brandfetch.io/GOOG/w/400/h/400?c=1idopYfmtR7ZKg8QMud Google Launches Gemini 3.8 Live With Live Avatar For Enterprise AI Agents Google has launched Gemini 3.8, an advanced AI model featuring a live avatar designed for enterprise applications. This new model aims to enhance user interaction and engagement in AI-driven environments. The launch reflects Google's ongoing commitment to innovation in artificial intelligence, although specific financial impacts or stock price movements related to this release were not detailed. https://www.openbell.ai/news/SFIX:1790265429689 2026-09-24T15:57:09.689Z daily 0.9 https://cdn.brandfetch.io/SFIX/w/400/h/400?c=1idopYfmtR7ZKg8QMud William Blair Downgrades Stitch Fix to Market Perform William Blair analyst Dylan Carden has downgraded Stitch Fix (NASDAQ: SFIX) from an 'Outperform' rating to 'Market Perform'. This change reflects a reassessment of the company's performance and outlook in the market. https://www.openbell.ai/news/SRRK:1790265373627 2026-09-24T15:56:13.627Z daily 0.9 https://cdn.brandfetch.io/SRRK/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Scholar Rock Holding, Raises Price Target to $77 Truist Securities analyst Srikripa Devarakonda has maintained a 'Buy' rating on Scholar Rock Holding (NASDAQ: SRRK) and raised the price target from $76 to $77. https://www.openbell.ai/news/PPL:1790265329805 2026-09-24T15:55:29.805Z daily 0.9 https://cdn.brandfetch.io/PPL/w/400/h/400?c=1idopYfmtR7ZKg8QMud PPL Electric Utilities Selected To Receive Up To $71.5M In Government Funding From U.S. Department Of Energy To Support Montour Grid Resilience, Advanced Reconductoring Project PPL Electric Utilities has been awarded up to $71.5 million in federal funding from the U.S. Department of Energy for the Montour Grid Resilience and Advanced Reconductoring Project. This initiative aims to modernize a 230-kilovolt transmission corridor and is part of the DOE's SPARK Program, which focuses on accelerating advanced transmission technology upgrades. https://www.openbell.ai/news/TLT:1790265302673 2026-09-24T15:55:02.673Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Benzinga-Quick-Spark.jpg?width=250&height=187 QUICK SPARK: The TLT ETF Tracking Long Duration Bonds Hits New Record Low The iShares 20+ Year Treasury Bond ETF (TLT) reached a record low of $79.71 as long-duration U.S. Treasury bonds experienced a sell-off. The 10-year Treasury yield rose to 5.11%, the highest since 2007, attributed to stronger-than-expected economic growth, with the U.S. Composite PMI at 58.4. Market analyst Ed Yardeni described the 5% yield as a 'vote of confidence' in the economy, while investor Peter Schiff warned it could lead to yields of 6% or higher, adding uncertainty ahead of the Federal Reserve's interest rate decision. https://www.openbell.ai/news/LGND:1790265245629 2026-09-24T15:54:05.629Z daily 0.9 https://cdn.brandfetch.io/LGND/w/400/h/400?c=1idopYfmtR7ZKg8QMud HC Wainwright & Co. Reiterates Buy on Ligand Pharmaceuticals, Maintains $358 Price Target HC Wainwright & Co. analyst Joseph Pantginis has reiterated a Buy rating on Ligand Pharmaceuticals (NASDAQ: LGND) and maintained a price target of $358. This endorsement suggests continued confidence in the company's performance and potential for growth. https://www.openbell.ai/news/TMO:1790265213561 2026-09-24T15:53:33.561Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Thermo-Fisher-Cambridge--Ma--Usa---June-.jpg?width=250&height=187 Thermo Fisher Stock Hits Record High: What's Happening? Thermo Fisher Scientific Inc. (NYSE: TMO) shares reached a record high of $681.55 on Thursday, surpassing its previous 52-week range, before settling around $668. This surge follows a strong second-quarter earnings report where the company reported adjusted earnings of $6.03 per share on nearly $12 billion in sales, a 10% year-over-year increase. Additionally, Thermo Fisher raised its full-year profit outlook to $24.93-$25.33 per share and sales guidance to $47.40 billion-$48.10 billion, anticipating a revenue growth of about 4%. https://www.openbell.ai/news/SEI:1790265126334 2026-09-24T15:52:06.334Z daily 0.9 https://cdn.brandfetch.io/SEI/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Solaris Energy Infr, Raises Price Target to $100 Citigroup analyst Scott Gruber has reaffirmed a Buy rating on Solaris Energy Infrastructure (NYSE: SEI) and increased the price target from $84 to $100. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/AMC:1790265048604 2026-09-24T15:50:48.604Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Kiev--Ukraine---February-9--2021-In-This.jpg?width=250&height=187 Why Is AMC Stock Falling on Thursday? AMC Entertainment's stock fell 4.70% to $2.74 on Thursday following the announcement of a $3.97 billion debt refinancing package. The company priced $2 billion in first lien senior secured notes due 2031 at an 8.875% interest rate and an $850 million term loan facility at SOFR plus 4.50%. The refinancing aims to delay heavy debt obligations due in 2029 to 2031, but high interest rates may restrict the company's free cash flow for years. https://www.openbell.ai/news/P:1790264959057 2026-09-24T15:49:19.057Z daily 0.9 https://cdn.brandfetch.io/P/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Maintains Buy on Everpure, Raises Price Target to $160 Citigroup analyst Asiya Merchant has reiterated a Buy rating on Everpure (NYSE: P) and increased the price target from $130 to $160. This adjustment reflects a positive outlook for the company's performance in the market. https://www.openbell.ai/news/ARCT:1790264843204 2026-09-24T15:47:23.204Z daily 0.9 https://cdn.brandfetch.io/ARCT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Upgrades Arcturus Therapeutics to Buy, Raises Price Target to $20 Citigroup analyst Yigal Nochomovitz has upgraded Arcturus Therapeutics (NASDAQ: ARCT) from Neutral to Buy. The price target for the stock has been raised significantly from $8 to $20. https://www.openbell.ai/news/SAIL:1790264768920 2026-09-24T15:46:08.920Z daily 0.9 https://cdn.brandfetch.io/SAIL/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on SailPoint, Raises Price Target to $27 Truist Securities analyst Junaid Siddiqui has maintained a Buy rating on SailPoint (NASDAQ: SAIL) and increased the price target from $23 to $27. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/TDY:1790264743276 2026-09-24T15:45:43.276Z daily 0.9 https://cdn.brandfetch.io/TDY/w/400/h/400?c=1idopYfmtR7ZKg8QMud Teledyne Energy Systems Partners With NASA To Advance Next-Gen Space Power Technology Under Space Act Agreement Teledyne Energy Systems, a subsidiary of Teledyne Technologies (NYSE: TDY), has partnered with NASA under a Space Act Agreement to advance next-generation space power technology. The collaboration aims to mature Teledyne's Hydrogen Electrical Power System (HEPS) from Technology Readiness Level 5 to TRL 7, enhancing power systems for future lunar and deep-space missions. https://www.openbell.ai/news/BB:1790264668950 2026-09-24T15:44:28.950Z daily 0.9 https://cdn.brandfetch.io/BB/w/400/h/400?c=1idopYfmtR7ZKg8QMud BlackBerry Raises Full-Year Outlook Again BlackBerry Limited reported a fiscal second-quarter revenue of $163.3 million, a 26% increase year-over-year, surpassing the $145.63 million estimate. The company raised its full-year revenue outlook to between $616 million and $636 million, up from a previous range of $594 million to $621 million, and adjusted EPS expectations to 19-22 cents from 16-20 cents. QNX revenue grew 27% to $80.3 million, and adjusted EBITDA increased 81% to $47 million. Despite a 4.06% drop in stock price to $8.045, BlackBerry continues to invest in QNX and explore growth opportunities in Physical AI. https://www.openbell.ai/news/KYTX:1790264666219 2026-09-24T15:44:26.219Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Budget-Bill-Sparks-National-Controversy.jpg?width=250&height=187 Kyverna Therapeutics Therapy Delivers Sustained Relief in Rare Neurological Conditions Kyverna Therapeutics Inc. (NASDAQ: KYTX) reported positive 12-month results from trials of its miv-cel cell therapy for stiff-person syndrome and generalized myasthenia gravis (gMG). The KYSA-8 study showed a 49% median improvement in walking performance among 26 patients, with 95% of those achieving initial improvements maintaining benefits after one year. Additionally, all seven participants in the KYSA-6 trial for gMG reported meaningful improvements in daily activities, with 86% remaining off immunosuppressive therapies. Kyverna plans to complete its rolling Biologics License Application submission by Q4 2026. https://www.openbell.ai/news/BB:1790264619193 2026-09-24T15:43:39.193Z daily 0.9 https://cdn.brandfetch.io/BB/w/400/h/400?c=1idopYfmtR7ZKg8QMud BlackBerry Raises Full-Year Outlook Again BlackBerry Limited reported fiscal second-quarter 2027 revenue of $163.3 million, a 26% year-over-year increase, surpassing the $145.63 million estimate. The company raised its full-year revenue outlook to between $616 million and $636 million, up from $594 million to $621 million, and adjusted EPS expectations to 19-22 cents from 16-20 cents. QNX revenue grew 27% to $80.3 million, and adjusted EBITDA increased 81% to $47 million. Despite a 4.06% drop in share price to $8.045, BlackBerry's management expressed confidence in future growth driven by software-defined vehicles and partnerships in Physical AI. https://www.openbell.ai/news/PBR:1790264616801 2026-09-24T15:43:36.801Z daily 0.9 https://cdn.brandfetch.io/PBR/w/400/h/400?c=1idopYfmtR7ZKg8QMud Petrobras CEO Speaking At RoG.e 2026 Says Company Close To Reaching 3M Barrels Per Day Of Oil Production Petrobras CEO announced at the RoG.e 2026 event that the company is nearing a milestone of 3 million barrels per day in oil production. This achievement reflects Petrobras's ongoing efforts to enhance its production capabilities. The announcement may have implications for the company's market position and stock performance, particularly for its ticker PBR. https://www.openbell.ai/news/BB:1790264574474 2026-09-24T15:42:54.474Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Blackberry.jpg?width=250&height=187 BlackBerry Raises Full-Year Outlook Again BlackBerry Limited reported a fiscal second-quarter revenue of $163.3 million, a 26% year-over-year increase, surpassing the $145.63 million estimate. The company raised its full-year revenue outlook to between $616 million and $636 million, up from a previous forecast of $594 million to $621 million, and adjusted EPS guidance to 19-22 cents from 16-20 cents. QNX revenue grew 27% to $80.3 million, contributing to an adjusted EBITDA of $47 million, an 81% increase. Despite a 4.06% drop in stock price to $8.045, BlackBerry remains optimistic about future growth opportunities in robotics and autonomous vehicles. https://www.openbell.ai/news/CTAS:1790264495241 2026-09-24T15:41:35.241Z daily 0.9 https://cdn.brandfetch.io/CTAS/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Cintas, Raises Price Target to $230 Truist Securities analyst Jasper Bibb has maintained a Buy rating on Cintas (NASDAQ: CTAS) and increased the price target from $225 to $230. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/SRZN:1790264490873 2026-09-24T15:41:30.873Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Eye-In-Close-Up-With-Light-Blue-Iris-Det.jpg?width=250&height=187 Surrozen Gains Momentum as FDA Submission Opens Path for Lead Therapy Surrozen Inc. (NASDAQ: SRZN) submitted an Investigational New Drug application to the FDA for its therapy SZN-8141, aimed at treating diabetic macular edema, leading to a 98.45% increase in its stock price to $32.07. The company plans to initiate a Phase 1b/2a clinical trial, DUET, with patient enrollment expected by late 2026 and initial results anticipated in the second half of 2027. As of June 30, Surrozen reported cash and cash equivalents of $102.0 million. https://www.openbell.ai/news/DBX:1790264462319 2026-09-24T15:41:02.319Z daily 0.9 https://cdn.brandfetch.io/DBX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Downgrades Dropbox to Sell, Lowers Price Target to $29 Citigroup analyst Steven Enders has downgraded Dropbox (NASDAQ: DBX) from Neutral to Sell and reduced the price target from $33 to $29. This change reflects a negative outlook on the company's performance. https://www.openbell.ai/news/BBNX:1790264383513 2026-09-24T15:39:43.513Z daily 0.9 https://cdn.brandfetch.io/BBNX/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Maintains Buy on Beta Bionics, Raises Price Target to $28 Truist Securities analyst Richard Newitter has maintained a 'Buy' rating on Beta Bionics (NASDAQ: BBNX) and raised the price target from $23 to $28. This adjustment reflects a positive outlook for the company's stock performance. https://www.openbell.ai/news/VSNT:1790264303847 2026-09-24T15:38:23.847Z daily 0.9 https://cdn.brandfetch.io/VSNT/w/400/h/400?c=1idopYfmtR7ZKg8QMud Citigroup Initiates Coverage On Versant Media Group with Buy Rating, Announces Price Target of $41 Citigroup analyst Jason Bazinet has initiated coverage on Versant Media Group (NASDAQ: VSNT) with a Buy rating. The firm has set a price target of $41 for the stock. https://www.openbell.ai/news/GOOG:1790264072105 2026-09-24T15:34:32.105Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Orbital-Data-Center-Satellite-In-Space-F.jpg?width=250&height=187 Google Moves Up its Space Data Center Timeline — Project Suncatcher Launches Oct. 1 Alphabet Inc. is set to launch its experimental AI satellite, MVP, as part of Project Suncatcher on October 1, months ahead of the original schedule for early 2027. The satellite will carry four Google tensor processing units and is designed to operate for about a year, with the capability to answer simple queries from orbit. Following this announcement, GOOGL stock was reported at $338.76, reflecting a 0.28% increase, while Planet Labs shares have risen approximately 38% since the project's unveiling, although they remain significantly below their 52-week high. https://www.openbell.ai/news/MSTR:1790264049618 2026-09-24T15:34:09.618Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Apex--North-Carolina---May-7-2025-Strate.jpg?width=250&height=187 Bitcoin Bets Go Into Overdrive As MSTR, Leveraged ETFs Surge MicroStrategy (NASDAQ: MSTR) has seen a nearly 29% increase in its stock price over the past five trading days, while leveraged ETFs tied to the company, such as MSTU, MSTP, and MSTX, have surged approximately 60%. The rally coincided with MicroStrategy's purchase of 950 Bitcoin for $75.7 million, increasing its total holdings to 846,000 Bitcoin. Despite a pullback on Wednesday, where MSTR fell 3.07% to $162.20, the overall trend reflects significant momentum in both the stock and associated ETFs. https://www.openbell.ai/news/VKTX:1790263943316 2026-09-24T15:32:23.316Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Viking-Therapeutics.jpg?width=250&height=187 Why Is Viking Therapeutics Stock Trading Down Thursday? Viking Therapeutics Inc. (NASDAQ: VKTX) shares fell by 15.61% to $35.15 after the company announced an upsized public offering of 7.85 million shares priced at $35 each and $225 million in convertible senior notes due 2032. The estimated net proceeds from the common stock offering are approximately $258.2 million, which will be used for the clinical development of its VK2735 and VK3019 programs, as well as for general corporate purposes. The stock remains above key moving averages, but analysts are monitoring support levels around $31.50. https://www.openbell.ai/news/FRVO:1790263939991 2026-09-24T15:32:19.991Z daily 0.9 https://cdn.brandfetch.io/FRVO/w/400/h/400?c=1idopYfmtR7ZKg8QMud Johnson Rice Initiates Coverage On Fervo Energy with Buy Rating, Announces Price Target of $35 Johnson Rice analyst Martin Malloy has initiated coverage on Fervo Energy (NASDAQ: FRVO) with a Buy rating. The firm has set a price target of $35 for the stock. https://www.openbell.ai/news/PENGU:1790263928811 2026-09-24T15:32:08.811Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Quito--Ecuador---Oct-28-2025--Dogecoin-I.jpg?width=250&height=187 Forget PEPE: PENGU Could Outrun DOGE, SHIB With a 1,200% Rally Pudgy Penguins (PENGU) has seen a 2% increase, extending its rally to nearly 38% over the past week, making it the sixth-largest cryptocurrency gainer. The token reached a five-month high of $0.0109 before a slight pullback and is currently trading at $0.0099. Analyst Ali Martinez suggests that PENGU's chart structure resembles that of Pepe's early expansion phase, indicating potential for a significant rally, with predictions of a 1,200% increase based on bullish technical signals. https://www.openbell.ai/news/META:1790263727179 2026-09-24T15:28:47.179Z daily 0.9 https://cdn.brandfetch.io/META/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Meta Platforms, Raises Price Target to $920 JP Morgan analyst Doug Anmuth has maintained an Overweight rating on Meta Platforms (NASDAQ: META) and raised the price target from $820 to $920. This adjustment reflects positive expectations for the company's performance in the market. https://www.openbell.ai/news/IP:1790263444057 2026-09-24T15:24:04.057Z daily 0.9 https://cdn.brandfetch.io/IP/w/400/h/400?c=1idopYfmtR7ZKg8QMud Argus Research Reiterates Buy on International Paper, Maintains $45 Price Target Argus Research analyst Alexandra Yates has reiterated a Buy rating on International Paper (NYSE: IP) and maintained a price target of $45 for the stock. This recommendation reflects confidence in the company's performance and potential for growth. https://www.openbell.ai/news/CBAT:1790263395951 2026-09-24T15:23:15.951Z daily 0.9 https://cdn.brandfetch.io/CBAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud UPDATE: CBAK Energy Announces Investment Agreement For 12 GWh Sodium-Ion Battery Project In Nanjing Was Announced September 23, 2026 CBAK Energy Technology Limited (NASDAQ: CBAT) has signed an investment agreement with the Nanjing Gaochun Economic Development Zone to develop large cylindrical sodium-ion battery cells and integrated systems in Nanjing, Jiangsu Province. This project will add 12 GWh of annual cell production capacity, supporting the company's sodium-ion expansion plan. https://www.openbell.ai/news/CBAT:1790263216563 2026-09-24T15:20:16.563Z daily 0.9 https://cdn.brandfetch.io/CBAT/w/400/h/400?c=1idopYfmtR7ZKg8QMud CBAK Energy Technology Inks Agreement With Nanjing Gaochun Economic Development Zone Over Large Cylindrical Sodium-Ion Battery Cells, Integrated Battery Systems In China CBAK Energy Technology Limited (NASDAQ: CBAT) has signed an investment agreement with the Nanjing Gaochun Economic Development Zone to develop and manufacture large cylindrical sodium-ion battery cells and integrated battery systems. This initiative will increase the company's annual production capacity by 12 gigawatt-hours (GWh), furthering its sodium-ion expansion strategy. https://www.openbell.ai/news/MMED:1790263035342 2026-09-24T15:17:15.342Z daily 0.9 https://cdn.brandfetch.io/MMED/w/400/h/400?c=1idopYfmtR7ZKg8QMud Truist Securities Initiates Coverage On Minimed Group with Buy Rating, Announces Price Target of $29 Truist Securities has initiated coverage on Minimed Group (NASDAQ: MMED) with a Buy rating. The firm has set a price target of $29 for the stock. https://www.openbell.ai/news/APUS:1790262909010 2026-09-24T15:15:09.010Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/Medical-Technology--Doctor-Use-Ai-Robots.jpg?width=250&height=187 Apimeds Pharmaceuticals Stock Skyrockets Thursday: What's Happening? Apimeds Pharmaceuticals (NYSE: APUS) shares surged by 132.31% to $5.31 following the announcement of a 12-month technology services agreement between its subsidiary, MindWave Innovations Inc., and AQUAE Holdings Pte. Ltd. Under this agreement, MindWave will develop and operate the AQUAEChain platform, earning service fees and a 20% allocation of all issued ALCI Credits. The agreement is effective from September 14 and includes an option for a five-year extension. https://www.openbell.ai/news/RCL:1790262747475 2026-09-24T15:12:27.475Z daily 0.9 https://cdn.brandfetch.io/RCL/w/400/h/400?c=1idopYfmtR7ZKg8QMud JP Morgan Maintains Overweight on Royal Caribbean Group, Raises Price Target to $394 JP Morgan analyst Matthew Boss has maintained an Overweight rating on Royal Caribbean Group (NYSE: RCL) and raised the price target from $345 to $394. This adjustment reflects a positive outlook on the company's performance. https://www.openbell.ai/news/BAC:1790262727264 2026-09-24T15:12:07.264Z daily 0.9 https://cdn.benzinga.com/files/images/story/2026/09/24/2024-11-15-Los-Angeles-Usa-Bank-Of-Ameri.jpg?width=250&height=187 Bank of America Bets $150 Million on America’s Workforce Bank of America Corp. announced a $150 million investment in U.S. workforce development, aiming to hire 1,000 additional apprentices over the next two years. This initiative is part of the bank's commitment to skills-based hiring and follows its previous investments of nearly $40 million in 2025. Additionally, the bank expects third-quarter investment banking fees to be between $1.6 billion and $1.8 billion, below consensus estimates of $2 billion, indicating a potential year-over-year decline of over 10%. As of Thursday, BAC shares were trading at $56.09, reflecting a slight increase of 0.16%. https://www.openbell.ai/news/F:1790262244919 2026-09-24T15:04:04.919Z daily 0.9 https://cdn.brandfetch.io/F/w/400/h/400?c=1idopYfmtR7ZKg8QMud 'Hyundai expected to outsell Ford in third quarter as Detroit automakers lack hybrids' - CNBC Hyundai is projected to surpass Ford in sales during the third quarter of 2026, driven by Ford's limited offerings in hybrid vehicles. The shift in consumer preference towards hybrids has put pressure on Detroit automakers, impacting their sales performance. This trend highlights the growing demand for fuel-efficient vehicles in the automotive market.